Moderate-to-severe atopic dermatitis in different age groups treated with dupilumab in China

被引：3
|
作者：
Song, Xiaoting [1 ,2 ,3 ,4 ]
Liu, Bo [1 ,2 ,3 ,4 ]
Luan, Tingting [1 ,2 ,3 ,4 ,5 ]
Liao, Shuanglu [1 ,2 ,3 ,4 ]
Tan, Yen [1 ,2 ,3 ,4 ]
Peng, Chengyue [1 ,2 ,3 ,4 ,5 ]
Zhao, Zuotao [1 ,2 ,3 ,4 ,6 ]
机构：
[1] Peking Univ First Hosp, Dept Dermatol & Venerol, Beijing, Peoples R China
[2] Beijing Key Lab Mol Diag Dermatoses, Beijing, Peoples R China
[3] Natl Clin Res Ctr Skin & Immune Dis, Beijing, Peoples R China
[4] NMPA Key Lab Qual Control & Evaluat Cosmet, Beijing, Peoples R China
[5] Peking Univ, Sch Nursing, Beijing, Peoples R China
[6] Peking Univ First Hosp, Dept Dermatol & Venereol, Xishiku Ave 8, Beijing 100034, Peoples R China
来源：
ALLERGY | 2023年 / 78卷 / 06期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1111/all.15660
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1696 / 1699
页数：4
相关论文
共 50 条
  • [21] Long-term follow-up in patients with moderate-to-severe atopic dermatitis treated with dupilumab
    Votto, M.
    Fortina, V.
    De Filippo, M.
    Naso, M.
    Villanova, M.
    Licari, A.
    Marseglia, G. L.
    Brazzelli, V.
    ALLERGY, 2023, 78
  • [22] Emerging Role of Atopic Dermatitis Control Tool in Long-Term Monitoring of Patients With Moderate-to-Severe Atopic Dermatitis Treated With Dupilumab
    Cioppa, Vittoria
    Lazzeri, Laura
    Carraro, Andrea
    De Piano, Ernesto
    Falcinelli, Francesca
    Galluzzo, Marco
    Pallotta, Sabatino
    De Pita, Ornella
    Russo, Filomena
    DERMATITIS, 2024, 35
  • [23] Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
    Mareschal, Adrien
    Puzenat, Eve
    Aubin, Francois
    ACTA DERMATO-VENEREOLOGICA, 2020, 100 (01)
  • [24] Drug survival of dupilumab compared to cyclosporin in moderate-to-severe atopic dermatitis patients
    Dal Bello, Giacomo
    Maurelli, Martina
    Schena, Donatella
    Girolomoni, Giampiero
    Gisondi, Paolo
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [25] Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis
    Kim, Nicole S.
    Maliyar, Khalad
    Oliveira, Luciana
    O'Toole, Ashley
    Gooderham, Melinda J.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (10) : E361 - E363
  • [26] Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
    Hamilton, Jennifer D.
    Suarez-Farinas, Mayte
    Dhingra, Nikhil
    Cardinale, Irma
    Li, Xuan
    Kostic, Ana
    Ming, Jeffrey E.
    Radin, Allen R.
    Krueger, James G.
    Graham, Neil
    Yancopoulos, George D.
    Pirozzi, Gianluca
    Guttman-Yassky, Emma
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (06) : 1293 - 1300
  • [27] Dupilumab Treatment Rapidly Improves Itch in Patients With Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan I.
    Chao, Jingdong
    Eckert, Laurent
    Chen, Zhen
    Ardeleanu, Marius
    Shumel, Brad
    Plaum, Stefan
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Gadkari, Abhijit
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 29 - 29
  • [28] DUPILUMAB TREATMENT RAPIDLY IMPROVES ITCH IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Silverberg, J.
    Chao, J.
    Eckert, L.
    Chen, Z.
    Ardeleanu, M.
    Shumel, B.
    Plaum, S.
    Graham, N.
    Pirozzi, G.
    Gadkari, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S95 - S95
  • [29] Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
    Ferrucci, Silvia
    Casazza, Giovanni
    Zussino, Martina
    Tavecchio, Simona
    Marzano, Angelo V.
    Tedeschi, Micol
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [30] Dupilumab (Dupixent) for Moderate to Severe Atopic Dermatitis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1519): : 64 - 66
12345